tiogapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Tioga |
| Description | Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic |
| Keywords | Tioga Pharmaceuticals, kappa-opioid receptor agonist, asimadoline |
Server Information
| WebSite | |
| Host IP | 64.71.35.21 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tiogapharma.com Valuation
|
US$1,186,235
Last updated: 2023-05-15 05:28:45
tiogapharma.com has Semrush global rank of 8,922,604. tiogapharma.com has an estimated worth of US$ 1,186,235, based on its estimated Ads revenue. tiogapharma.com receives approximately 136,874 unique visitors each day. Its web server is located in United States, with IP address 64.71.35.21. According to SiteAdvisor, tiogapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,186,235 |
| Daily Ads Revenue | US$1,095 |
| Monthly Ads Revenue | US$32,850 |
| Yearly Ads Revenue | US$394,195 |
| Daily Unique Visitors | 9,125 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tiogapharma.com. | A | 3600 | IP: 64.71.35.21 |
| tiogapharma.com. | NS | 3600 | NS Record: ns53.domaincontrol.com. |
| tiogapharma.com. | NS | 3600 | NS Record: ns54.domaincontrol.com. |
| tiogapharma.com. | MX | 3600 | MX Record: 0 tiogapharma-com.mail.protection.outlook.com. |
| tiogapharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-15 05:28:45
| Tioga Pharmaceuticals Clinical development of a novel small molecule therapeutic for women’s health Additional information available soon. Asimadoline is a novel, orally active, highly selective kappa-opioid receptor agonist. Asimadoline has been administered to over 1500 subjects and is well-tolerated. Asimadoline has the potential to provide symptomatic relief of pruritus associated with several skin and systemic diseases. --> ©2022 Tioga Pharmaceuticals. All rights |
HTTP Headers
HTTP/1.1 200 OK Date: Fri, 24 Dec 2021 18:40:12 GMT Server: Apache Last-Modified: Fri, 16 Dec 2016 22:50:52 GMT ETag: "ab9-543ce66e28b00" Accept-Ranges: bytes Content-Length: 2745 Vary: Accept-Encoding Content-Type: text/html |
tiogapharma.com Whois Information
Domain Name: TIOGAPHARMA.COM Registry Domain ID: 169893456_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-09T20:22:23Z Creation Date: 2005-06-14T16:36:01Z Registry Expiry Date: 2024-06-14T16:36:01Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-28T07:54:17Z <<< |